BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16393861)

  • 1. Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites.
    Mallants R; Van Oosterwyck K; Van Vaeck L; Mols R; De Clercq E; Augustijns P
    Xenobiotica; 2005; 35(10-11):1055-66. PubMed ID: 16393861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures.
    van Gelder J; Deferme S; Naesens L; De Clercq E; van den Mooter G; Kinget R; Augustijns P
    Drug Metab Dispos; 2002 Aug; 30(8):924-30. PubMed ID: 12124311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tubular transporters OAT1 and MRP2 and clearance of adefovir].
    Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
    Nephrol Ther; 2005 Nov; 1(5):296-300. PubMed ID: 16895698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific bidirectional efflux of 2,4-dinitrophenyl-S-glutathione, a substrate of multidrug resistance-associated proteins, in rat intestine and Caco-2 cells.
    Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
    J Pharm Pharmacol; 2007 Apr; 59(4):513-20. PubMed ID: 17430634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta.
    Neumanova Z; Cerveny L; Ceckova M; Staud F
    AIDS; 2014 Jan; 28(1):9-17. PubMed ID: 24413260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular transporters and clearance of adefovir.
    Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
    Eur J Pharmacol; 2006 Jul; 540(1-3):168-74. PubMed ID: 16756973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
    Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
    Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment.
    Kearney BP; Yale K; Shah J; Zhong L; Flaherty JF
    Clin Pharmacokinet; 2006; 45(11):1115-24. PubMed ID: 17048975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
    Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
    J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
    Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
    J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
    Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute regulation of multidrug resistance-associated protein 2 localization and activity by cAMP and estradiol-17β-D-glucuronide in rat intestine and Caco-2 cells.
    Tocchetti GN; Arias A; Arana MR; Rigalli JP; Domínguez CJ; Zecchinati F; Ruiz ML; Villanueva SSM; Mottino AD
    Arch Toxicol; 2018 Feb; 92(2):777-788. PubMed ID: 29052767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probenecid on the biliary excretion of belotecan.
    Namkoong EM; Kim IW; Kim DD; Chung SJ; Shim CK
    Arch Pharm Res; 2007 Nov; 30(11):1482-8. PubMed ID: 18087819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of multidrug resistance-associated protein 2 in acute hepatic failure rats.
    Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
    Eur J Pharmacol; 2006 Sep; 546(1-3):152-60. PubMed ID: 16899240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of genistein, a natural soy isoflavone, on the pharmacokinetics and intestinal toxicity of irinotecan hydrochloride in rats.
    Yokooji T; Kawabe Y; Mori N; Murakami T
    J Pharm Pharmacol; 2013 Feb; 65(2):280-91. PubMed ID: 23278696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.
    Sugie M; Asakura E; Zhao YL; Torita S; Nadai M; Baba K; Kitaichi K; Takagi K; Takagi K; Hasegawa T
    Antimicrob Agents Chemother; 2004 Mar; 48(3):809-14. PubMed ID: 14982769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.
    Kiser JJ; Carten ML; Aquilante CL; Anderson PL; Wolfe P; King TM; Delahunty T; Bushman LR; Fletcher CV
    Clin Pharmacol Ther; 2008 Feb; 83(2):265-72. PubMed ID: 17597712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.
    Imaoka T; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
    Mol Pharmacol; 2007 Feb; 71(2):619-27. PubMed ID: 17110501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats.
    Naruhashi K; Tamai I; Inoue N; Muraoka H; Sai Y; Suzuki N; Tsuji A
    Antimicrob Agents Chemother; 2002 Feb; 46(2):344-9. PubMed ID: 11796340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
    Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.